Efficient photodynamic therapy against gram-positive and gram-negative bacteria using THPTS, a cationic photosensitizer excited by infrared wavelength

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Schastak, Stanislaw ^a   Ziganshyna, Svitlana ^a   Gitter, Burkhard ^b   Wiedemann, Peter ^a   Claudepierre, Thomas ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Biolitec AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METICILLIN; PHOSPHATE BUFFERED SALINE; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE; TETRAHYDROPORPHYRIN TETRATOSYLATE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIAL VIABILITY; BACTERICIDAL ACTIVITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; ILLUMINATION; INCUBATION TIME; INFRARED RADIATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; CHEMISTRY; METHODOLOGY; MICROBIAL VIABILITY; PHOTOCHEMOTHERAPY; RADIATION EXPOSURE;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEGIBACTERIA; POSIBACTERIA;

ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; INFRARED RAYS; MICROBIAL VIABILITY; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 77955363538     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011674     Document Type: Article

References (42)

1. Rammelkamp M (1942) Resistance of Staphylococcus aureus to the action of penicillin. Proc Soc Exp Biol Med 51: 386-389.
2. Felmingham D, White AR, Jacobs MR, Appelbaum PC, Poupard J, et al. (2005) The Alexander Project: the benefits from a decade of surveillance. J Antimicrob Chemother 56: 3-21.
3. Jones RN (2003) Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY Antimicrobial Surveillance Program (1997-2001). Semin Respir Crit Care Med 24: 121-134.
4. Mackenzie FM, Bruce J, Van Looveren M, Cornaglia G, Gould IM, et al. (2006) Antimicrobial susceptibility testing in European hospitals: report from the ARPAC study. Clin Microbiol Infect 12: 1185-1192.
5. Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR (2007) Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis 57: 7-13.
6. Jevons MP, Coe AW, Parker MT (1963) Methicillin resistance in staphylococci. Lancet 1: 904-907.
7. Diekema DJ, BootsMiller BJ, Vaughn TE, Woolson RF, Yankey JW, et al. (2004) Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clin Infect Dis 38: 78-85.
8. National Nosocomial Infections Surveillance System (2004) National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32: 470-485.
9. Boucher HW, Corey GR (2008) Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 46: 344-349.
10. Fridkin SK (2001) Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis 32: 108-115.
11. Sievert D, Boulton M, Stoltman G, Johnson D, Stobierski M, et al. (2002) Staphylococcus aureus resistant to vancomycin-United States. MMWR Morb Mortal Wkly Rep 51: 565-567.
12. EARSS (European Antimicrobial Resistance Surveillance System) Study 2006, 21-74.
13. Witte W, Mielke M (2007) Community MRSA. Zentralbl Chir 132: 124-129.
14. Raab O (1900) Ueber die Wirkung fluorizierender Stoffe auf Infusorien. Z Biol 39: 524-546.
15. Tappeiner Hv (1904) Zur Kenntnis der lichtwirkenden (fluoreszierenden) Stoffe. Dtsch Med Wochenschr 1: 579-580.
16. Tappeiner Hv, Jodlbauer A (1904) Über die Wirkung der photodynamischen (fluoreszierenden) Stoffe auf Infusorien. Dtsch Arch Klin Med 80: 427-487.
17. MacDonald IJ, Dougherty TJ (2001) Basic principles of photodynamic therapy. J Porphyr Phthalocyanine 5: 105-129.
18. Hamblin MR, Hasan T (2004) Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci 3: 436-450.
19. Wainwright M, Crossley KB (2004) Photosensitizing agents circumventing resistance and breaking down biofilms: a review. Int Biodeterior Biodegrad 53: 119-126.
20. Jori G, Fabris C, Soncin M, Ferro S, Coppellotti O, et al. (2006) Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications. Lasers Surg Med 38: 468-481.
21. Jori J (2006) Photodynamic Therapy of Microbial Infections: State of the Art and Perspectives. J Environ Path Toxcol Oncol 25: 505-519.
22. Maisch T (2007) Anti-microbial photodynamic therapy: useful in the future? Lasers Med Sci 22: 83-91.
23. Ferro S, Ricchelli F, Monti D, Mancini G, Jori G (2007) Efficient photoinactivation of methicillin-resistant Staphylococcus aureus by a novel porphyrin incorporated into a poly-cationic liposome. Int J Biochem Cell Biol 39: 1026-1034.
24. Nitzan Y, Gozhansky S, Malik Z (1985) Effect of photoactivated hematoporphyrin derivative on the viability of Staphylococcus aureus. Current Microbiology 8: 279-284.
25. Maisch T, Bosl C, Szeimies RM, Lehn N, Abels C (2005) Photodynamic Effects of Novel XF Porphyrin Derivatives on Prokaryotic and Eukaryotic Cells. Antimicrobial Agents and Chemotherapy 49: 1542-1552.
26. Banfi S, Caruso E, Buccafurni L, Battini V, Zazzaron S, et al. (2006) Antibacterial activity of tetraaryl-porphyrin photosensitizers: An in vitro study on Gram negative and Gram positive bacteria. J Photochem Photobiol B 85: 28-38.
27. Lazzeri D, Rovera M, Pascual L, Durantini EN (2004) Photodynamic studies and photoinactivation of Escherichia coli using meso-substituted cationic porphyrin derivatives with asymmetric charge distribution. Photochem Photobiol 80: 286-293.
28. Caminos DA, Spesia MB, Durantini EN (2006) Photodynamic inactivation of Escherichia coli by novel meso-substituted porphyrins by 4-(3-N,N,N-trimethylammoniumpropoxy) phenyl and 4-(trifluoromethyl)phenyl groups. Photochem Photobiol Sci 5: 56-65.
29. Alves E, Costa L, Carvalho CMB, Tomé JPC, Maria A, et al. (2009) Charge effect on the photoinactivation of Gram-negative and Gram-positive bacteria by cationic meso-substituted porphyrins. BMC Microbiology 9: 70.
30. Costa L, Alves E, Carvalho CM, Tomé JP, Faustino MA, et al. (2008) Sewage bacteriophage photoinactivation by cationic porphyrins: a study of charge effect. Photochem Photobiol Sci 7: 415-422.
31. Engelmann FM, Mayer I, Gabrielli DS, Toma HE, Kowaltowski AJ, et al. (2007) Interaction of cationic meso-porphyrins with liposomes, mitochondria and erythrocytes. J Bioenerg Biomembr 39: 175-185.
32. Susin SA, Zamzami N, Kroemer G (1998) Mitochondria as regulators of apoptosis. Biochim Biophys Acta 1366: 151-165.
33. Schastak S, Yafai Y, Geyer W, Kostenich G, Orenstein A, et al. (2008) Initiation of apoptosis by photodynamic therapy using a novel positively charged and water soluble near infra-red photosensitizer and white light irradiation. Methods Find Exp Clin Pharmacol 30: 129-133.
34. Maisch T, Bosl C, Szeimies RM, Love B, Abels C (2007) Determination of the antibacterial efficacy of a new porphyrins-based photosensitizer against MRSA ex vivo. Photochem Photobiol Sci 6: 545-551.
35. Fotinos N, Convert M, Piffaretti JC, Gurny R, Lange N (2008) Effects on gramnegative and gram-positive bacteria mediated by 5-aminolevulinic Acid and 5- aminolevulinic acid derivatives. Antimicrob Agents Chemother 52: 1366-1373.
36. Seaton RA (2008) Daptomycin: rationale and role in the management of skin and soft tissue infections. J Antimicrob Chemother 62: 15-23.
37. Gupta MR, Valentine VG, Walker JE, Jr., Lombard GA, LaPlace SG, et al. (2009) Clinical spectrum of gram-positive infections in lung transplantation. Transpl Infect Dis 11: 424-431.
38. Jenkins TC, McCollister BD, Sharma R, McFann KK, Madinger NE, et al. (2009) Epidemiology of healthcare-associated bloodstream infection caused by USA300 strains of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Infect Control Hosp Epidemiol 30: 233-241.
39. Gillham MI, Sundaram S, Laughton CR, Haworth CS, Bilton D, et al. (2009) Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis. J Antimicrob Chemother 63: 728-732.
40. Lin YM, Wu SJ, Chang TW, Wang CF, Suen CS, et al. (2010) Outer membrane protein I of Pseudomonas aeruginosa is a target of cationic antimicrobial peptide/protein. J Biol Chem 285: 8985-8594.
41. Hamblin MR, Zahra T, Contag CH, McManus AT, Hasan T (2003) Optical monitoring and treatment of potentially lethal wound infections in vivo. J Infect Dis 187: 1717-1725.
42. Zolfaghari PS, Packer S, Singer M, Nair SP, Bennett J, et al. (2009) In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent. BMC Microbiol 9: 27.